Erratum: Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force (Clinical and Experimental Otorhinolaryngology 2023;16(4):291-307. https://doi.org/10.21053/ceo.2023.00458)

In the article entitled “Guidelines for the Use of Botulinum Toxin in Otolaryngology From the Korean Society of Laryngology, Phoni-atrics and Logopedics Guideline Task Force,” published in Clinical and Experimental Otorhinolaryngology, the recommendation statement for KQ 8 was incorrectly published. The correct recommendation statement is as follows: KQ 8. Is BT injection effective for the treatment of patients with sialorrhea? Recommendation Direct BT injection to the salivary gland reduces saliva flow in patients with sialorrhea. (Strong recommendation, Moderate-quality evidence).